Gene therapy for hemophilia: So close, yet so far away
Bio Pharma Dive
JANUARY 28, 2021
Significant setbacks for pace-setting programs from BioMarin and UniQure have renewed questions about gene therapy’s promise, and its safety.
Sat.Jan 23, 2021 - Fri.Jan 29, 2021
358 
10 Essential pharma content strategy must-haves
World of DTC Marketing
JANUARY 27, 2021
SUMMARY: Pharma has not embraced a content strategy when the number of online health seekers is climbing. A content management strategy can lead to a better brand-patient relationship and turn customers into brand ambassadors. I’m not a huge believer in content strategy for CPGs. I feel that there is so much content already out there that people don’t have the time to read it all.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Researchers identify existing drug’s potential for triple negative breast cancer
Pharma Times
JANUARY 28, 2021
Study suggests that palbociclib could be used to treat around a fifth of people with TNBC
Over-the-Counter Nasal Spray Could Be Effective Against COVID-19
BioSpace
JANUARY 25, 2021
An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Vaccine makers prepare response as coronavirus mutations raise alarms
Bio Pharma Dive
JANUARY 28, 2021
So far, both Pfizer's and Moderna's vaccines appear to work against more transmissible variants, but preparation is underway for the day they don't.
The complicated ROI measurement for pharma
World of DTC Marketing
JANUARY 25, 2021
SUMMARY: The LinkedIn team had a unique take on measuring ROI. “77% of marketers measure ROI within the first month of their campaign, knowingly trying to “prove ROI in a shorter amount of time than their typical sales cycle., while only 4% of marketers even measure ROI over a six-month period or longer.” So how should DTC marketers really measure ROI?
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Moderna says its COVID-19 vaccine works effectively against variants
Pharma Times
JANUARY 26, 2021
Lab tests evaluated vaccine's efficacy against UK and South African variants
Sanofi, in unusual move, to help Pfizer, BioNTech make coronavirus vaccine doses
Bio Pharma Dive
JANUARY 26, 2021
The French drugmaker, having hit delays with its own coronavirus shot, agreed to manufacture over 100 million doses of Pfizer and BioNTech's vaccine for supply in Europe.
Is pharma digital ready?
World of DTC Marketing
JANUARY 26, 2021
SUMMARY: Digital is a way of thinking; it’s not a tactic. To many going digital can mean a ton of opportunities but if you move too quickly you can lose sight of the end goal. Is your organization digital ready? It’s a question that I ask all of my clients at a time when more people are going online for health information. But let’s start at the beginning… 1ne: What’s the purpose of your product website?
Unlocking health data to improve oncology outcomes
pharmaphorum
JANUARY 27, 2021
As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial health data and real-world evidence (RWE) environment. It’s one that has global potential to improve patient outcomes but efforts to harness the true potential of these information flows are only just beginning. The foundation for this is the NHS’ longstanding commitment to collecting healthcare data.
FDA Designations for Rare Disease Products, Part 1
Camargo
JANUARY 27, 2021
Comparing Orphan Drug, Rare Pediatric Disease, and Humanitarian Use Device Designations. The US FDA offers sponsors a variety of special designation programs to incentivize them to develop and deliver therapies to treat unmet patient needs, such as Fast Track Designation (FTD), Breakthrough Therapy Designation , and Qualified Infectious Disease Product Designation.
J&J says single dose of coronavirus vaccine 66% effective in large trial
Bio Pharma Dive
JANUARY 29, 2021
The vaccine's efficacy was higher in the U.S., but lower in Latin America and South Africa, where new, more infectious virus variants are circulating.
Selling digital to skeptics within pharma
World of DTC Marketing
JANUARY 29, 2021
SUMMARY: The future of healthcare involves digital transformation but moving too fast in a matrix management environment can cause problems and set digital back months. Most of us know the importance of digital when to comes to healthcare. The pandemic has accelerated digital transformation, but organizations need to be careful about moving too fast without getting company influencers’ buy-in.
What we’re expecting in 2021, and beyond…
pharmaphorum
JANUARY 26, 2021
From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare. There are several important aspects to these shifts for pharma, biotech and medical device companies, so what can we expect to see over the next 12 months and beyond?
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Valneva completes recruitment for Phase I/II COVID-19 vaccine study
Pharma Times
JANUARY 29, 2021
Speciality vaccine company has also started production of vaccine candidate
Merck stops coronavirus vaccine development in surprise setback
Bio Pharma Dive
JANUARY 25, 2021
The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials.
Inria and InSilicoTrials partner up on a European project leveraging simulation for cardiac devices and drugs
Pharma Mirror
JANUARY 26, 2021
Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is particularly difficult in the case of cardiovascular disease, which remains the leading cause of death worldwide, with 18 million deaths each year according to World Health Organization estimates.
Bad news for Pfizer as blockbuster Xeljanz flunks safety study
pharmaphorum
JANUARY 29, 2021
JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety has achieved the opposite. The post-marketing safety study showed that Xeljanz (tofacitinib) – used to treat rheumatoid arthritis (RA) – was associated with a higher rate of heart attacks and cancer than a TNF inhibitor in patients aged over 50 with underlying cardiovascular risk factors.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
UK will offer its genomic expertise worldwide to identify new COVID-19 variants
Pharma Times
JANUARY 28, 2021
The New Variant Assessment Platform will be led by Public Health England
Safety finding weighs on Pfizer's inflammation drug, and could spell trouble for others
Bio Pharma Dive
JANUARY 27, 2021
A large safety study found that patients given Pfizer's Xeljanz had health issues like major heart complications and cancer at a higher rate than those who got a different kind of anti-inflammation drug.
Inria and InSilicoTrials partner up on a European project leveraging simulation for cardiac devices and drugs
Pharma Mirror
JANUARY 26, 2021
Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is particularly difficult in the case of cardiovascular disease, which remains the leading cause of death worldwide, with 18 million deaths each year according to World Health Organization estimates.
Are Gene Therapies the Medicine of the Future?
BioSpace
JANUARY 25, 2021
Gene therapies offer great reward in the form of treating various devastating diseases, but there are also significant risks.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
NICE recommends Revlimid for newly diagnosed multiple myeloma patients
Pharma Times
JANUARY 27, 2021
Cost-effectiveness agency initially turned down the drug in this setting
Can new Regeneron, Lilly data move the needle for COVID-19 antibody drugs?
Bio Pharma Dive
JANUARY 26, 2021
The results show that drugs from both companies can help prevent or treat COVID-19 when given at the right time. But that won't mean much if barriers to use remain high.
How Different Crimes Can Affect Your Nursing License in Georgia
Pharma Mirror
JANUARY 26, 2021
Navigating your way to a career in the medical field is not easy. You may have spent late nights studying for exams and long hours working in a medical institute. But, you are finally here about to get your nursing license in the state of Georgia. When applying for a nursing license or getting your old one renewed, you might face some trouble if the background check doesn’t show up clean.
COVID drives a customer experience shift in life sciences CRM
pharmaphorum
JANUARY 29, 2021
The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. Gartner’s’ CRM market guide notes that AI, digital scalability and hyper-automation hold the keys to sales success in the post-COVID era, and they highlight the providers who are using digital transformation to find new ways of engaging customers.
AbbVie's Rinvoq bags two new EU approvals
Pharma Times
JANUARY 26, 2021
Oral JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis
With latest deal, Merck wades into cell therapy for cancer
Bio Pharma Dive
JANUARY 28, 2021
A small upfront payment gives Merck access to a program from Artiva Biotherapeutics that aims to create "off-the-shelf" CAR-NK cell therapies for solid tumors.
Biden Pledges to Speed Flow of Vaccines to the States
NY Times
JANUARY 26, 2021
President Biden said the amount of coronavirus vaccines reaching the states would rise next week and a deal was near to provide enough shots to vaccinate nearly all Americans by the end of summer.
Clinical research in 2021: A new era of collaboration and innovation
pharmaphorum
JANUARY 25, 2021
The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content